MFA Advises TTE Laboratories in Sale to Transcat
We are pleased to announce that TTE Laboratories, Inc. was recently acquired by Transcat, Inc. (Nasdaq: TRNS).
MFA’s affiliate, MFA Capital Advisors, was the exclusive financial advisor providing consulting and advisory services to TTE, and the transaction was facilitated by MFA Securities (also an affiliate of MFA). Terms of the transaction were not disclosed.
A Massachusetts-based provider of metrology-based, audit-ready pipette calibration services, TTE specializes in a metrology-driven approach compliant with both ISO 17025 and 8655 calibration standards. Transcat is a leading provider of accredited calibration, repair, inspection and laboratory instrument services with clients spread across industries including biotechnology, medical device manufacturing, aerospace and defense, and pharmaceuticals.
Benjamin Leverone, President and CEO of TTE, said “Everyone at MFA brought a different area of strength to the transaction, which helped guide the process through to the end. We had a great working relationship and will always value the expertise, professionalism and drive they brought to helping us achieve our goal.”
“I’ve known the team at TTE for more than a decade, and I’m thrilled we were able to support them in finding a like-minded strategic partner,” said Laura Moruzzi, Partner at MFA. “TTE and Transcat share great synergy, and we’re confident that, united, they will continue to provide superior calibration services to the life sciences market in New England and across the country.”
Material discussed in this communication is meant to provide general information and should not be acted on without obtaining professional advice tailored to you or your company’s individual and specific needs. Any tax advice contained in this communication (including any attachments) is not intended or written to be used, and cannot be used by any person or entity, for the purpose of (i) avoiding penalties that may be imposed on any taxpayer or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein. This information is for general guidance only and is not a substitute for professional advice.
The information contained herein should not be construed as personalized investment advice. Investment in securities involves the risk of loss, and past performance is no guarantee of future results. There is no guarantee that the views and opinions expressed in this document will come to pass. Historical performance results for investment indexes and/or categories generally do not reflect the deduction of transaction and/or custodial charges or the deduction of an investment-management fee, the incurrence of which would have the effect of decreasing historical performance results. There can be no assurances that your portfolio will match or outperform any particular benchmark.
Information presented is believed to be factual and up-to-date; however, MFA makes no guarantee as to accuracy, completeness, suitability, or validity of any information within this communication and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages from its display or use. Any forward-looking statements are believed to be reasonable; however, MFA gives no assurance that such expectations will prove to be correct.